ISRCTN16586512已完成不适用
Mesothelioma - Early versus Delayed Chemotherapy
The Royal Marsden NHS Foundation Trust (UK)0 个研究点目标入组 43 人开始时间: 2002年8月19日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 43
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with histologically verified malignant mesothelioma - Performance status (PS) 0-2 - Asymptomatic or stable symptoms
- •2. Age at least 18 years
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
2 期
Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant MesotheliomaMesotheliomaNCT00295503University of Texas Southwestern Medical Center53
招募中
1 期
Optimising regulatory T cell depletion with cyclophosphamide in combination with chemotherapy for enhanced anti-tumour immunity in patients with non-small cell lung cancer (NSCLC) and malignant mesothelioma (MM).Malignant MesotheliomaNon small cell lung cancerCancer - Lung - MesotheliomaCancer - Lung - Non small cellACTRN12609000260224Sir Charles Gairdner Hospital33
进行中（未招募）
Unknown
Tumor volume measurements vs diameter-based measurements (mRECIST) for response evaluation in pleural mesotheliomaCancerPleural mesotheliomaISRCTN12418979Antoni van Leeuwenhoek Hospital52
进行中（未招募）
1 期
Mesothelioma Stratified Therapy (MiST) - Including the following treatment arms: MiST 1 rucaparib MiST 2 abemaciclib MiST 3 pembrolizumab in combination with bemcentinib MiST 4 atezolizumab in combination with bevacizumabMalignant Mesothelioma (MM) - pleural and peritonealEUCTR2017-003353-41-GBniversity of Leicester120
尚未招募
3 期
pfront Surgery Vs Induction Chemotherapy Followed By Surgery In Oral Cavity Squamous Cell CancersCTRI/2024/03/064586Indian Council of Medical Research